<DOC>
	<DOCNO>NCT02399306</DOCNO>
	<brief_summary>This randomize , prospective , multicenter study . The aim study compare change body weight , survival , toxicity , quality life opportunistic infection frequency Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma chemoradiotherapy without enteral nutrition therapy .</brief_summary>
	<brief_title>Chemoradiotherapy With Without Enteral Nutrition Intervention Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>18 75 year old , male female Pathologically cytologically proven thoracic middlelower esophageal squamous cell carcinoma Clinical stage II stage III PGSGA：Class B（score 28）Class C（score ≧9 ) Primary tumor measure Karnofsky score &gt; 70 Estimated life expectancy least 12 week Reproductive age woman ensure enter study period contraception Hemoglobin≥90.0g/dL , white blood cell count（WBC）≥ 4000 cells/mm³ , Platelet count≥100,000 cells/mm³ Aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) &lt; 2.5 time upper limit normal , bilirubin normal Creatinine normal OR creatinine clearance ≥ 60 mL/min Patients good compliance treatment followup acceptance Forced expiratory volume one second（FEV1） ≥ 1.5 litre ≥ 75 % reference value Considered operable ( i.e . appropriate organ function ability undergo general anesthesia ) No severe uncontrolled cardiovascular disease No active uncontrolled infection 1 . Patients severely bowel function impair tolerate enteral nutrition 2 . Patients serious gastrointestinal obstruction , unable take food mouth / want feed tube insert 3 . Patients risk malnutrition 4 . Patients severe vomit , gastrointestinal bleeding , intestinal obstruction 5 . Patients tolerate chemotherapy 6 . Patients distant metastasis 7 . The primary tumor lymph node already receive surgical treatment ( except biopsy ) ; 8 . Patient receive radiotherapy primary tumor lymph node ; 9 . Patient receive epidermal growth factor target therapy ; 10 . Patient receive chemotherapy immunotherapy ; 11 . Patient suffer malignant tumor ; 12 . Patient take drug test within 1 month ; 13 . Pregnant woman Lactating Women Women productive age refuse take contraception observation period ; 14 . Subject severe allergic history idiosyncratic ; 15 . Subject severe pulmonary cardiopathic disease history ; 16 . Refuse incapable sign inform consent form participate trial ; 17 . Drug abuse alcohol addict ; 18 . Subject Personality psychiatric disease , people legal ; capacity people limited capacity civil conduct ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>